Short Interfering RNA (siRNA) - Mediated RNA Interference (RNAi) in Human Cells

Annals of the New York Academy of Sciences

Volumn 1002, Issue , 2003, Pages 56-62

  Caplen, Natasha J ^a   Mousses, Spyro ^b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

RNA interference; RNAi gene silencing; Short interfering RNAs; siRNAs

Indexed keywords

ANTHRACYCLINE; DOUBLE STRANDED RNA; NUCLEOTIDE; SMALL INTERFERING RNA; TAXANE DERIVATIVE; TRASTUZUMAB;

BREAST CANCER; CONFERENCE PAPER; EUKARYOTE; GENE FUNCTION; GENE SILENCING; GENETIC ANALYSIS; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; MAMMAL CELL; METASTASIS; NONHUMAN; RNA INTERFERENCE;

EUKARYOTA; MAMMALIA;

EID: 1342268939     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1281.007     Document Type: Conference Paper

References (63)

1. ELBASHIR, S.M., W. LENDECKEL & T. TUSCHL. 2001. RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev. 15: 188-200.
2. ELBASHIR, S.M. et al. 2001. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20: 6877-6888.
3. HAMILTON, A.J. & D.C. BAULCOMBE. 1999. A species of small antisense RNA in post-transcriptional gene silencing in plants. Science 286: 950-952.
4. NAPOLI, C., C. LEMIEUX & R. JORGENSEN. 1990. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2: 279-289.
5. ROMANO, N. & G. MACINO. 1992. Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol. Microbiol. 6: 3343-3353.
6. FIRE, A. et al. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
7. KENNERDELL, J.R. & R.W. CARTHEW. 1998. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95: 1017-1026.
8. MISQUITTA, L. & B.M. PATERSON. 1999. Targeted disruption of gene function in Drosophila by RNA interference (RNA-i): a role for nautilus in embryonic somatic muscle formation. Proc. Natl. Acad. Sci. USA 96: 1451-1456.
9. BERNSTEIN, E. et al. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366.
10. HAMMOND, S.M. et al. 2000. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404: 293-296.
11. HAMMOND, S.M. et al. 2001. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293: 1146-1150.
12. ZAMORE, P.D. et al. 2000. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101: 25-33.
13. CLEMENS, M.J. & A. ELIA. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17: 503-524.
14. MINKS, M.A. et al. 1979. Structural requirements of double-stranded RNA for the activation of 2′,5′-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J. Biol. Chem. 254: 10180-10183.
15. MANCHE, L. et al. 1992. Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell Biol. 12: 5238-5248.
16. CAPLEN, N.J. et al. 2001. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 98: 9742-9747.
17. ELBASHIR, S.M. et al. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
18. CAPLEN, N.J. et al. 2000. dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference. Gene 252: 95-105.
19. CLEMENS, J.C. et al. 2000. Use of double-stranded RNA interference in drosophila cell lines to dissect signal transduction pathways. Proc. Natl. Acad. Sci. USA 97: 6499-6503.
20. ELBASHIR, S.M. et al. 2002. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213.
21. HOLEN, T. et al. 2002. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30: 1757-1766.
22. CHIU, Y.L. & T.M. RANA. 2002. RNAi in human cells: basic structural and functional features of small interfering RNA. Mol. Cell. 10: 549-561.
23. HAMADA, M. et al. 2002. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3′-ends of siRNAs. Antisense Nucleic Acid Drug Dev. 12: 301-309.
24. AMARZGUIOUI, M. et al. 2003. Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 31: 589-595.
25. ZENG, Y. & B.R. CULLEN. 2002. RNA interference in human cells is restricted to the cytoplasm. RNA 8: 855-860.
26. SUI, G. et al. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99: 5515-5520.
27. BRUMMELKAMP, T.R., R. BERNARDS & R. AGAMI. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
28. MCMANUS, M.T. et al. 2002. Gene silencing using micro-RNA designed hairpins. RNA 8: 842-850.
29. PAUL, C.P. et al. 2002. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20: 505-508.
30. LEE, N.S. et al. 2002. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20: 500-505.
31. MIYAGISHI, M. & K. TAIRA. 2002. U6 promoter driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20: 497-500.
32. Yu, J.Y., S.L. DERUITER & D.L. TURNER. 2002. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 99: 6047-6052.
33. FRASER, A.G. et al. 2000. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408: 325-330.
34. GONCZY, P. et al. 2000. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 408: 331-336.
35. PIANO, F. et al. 2000. RNAi analysis of genes expressed in the ovary of Caenorhabditis elegans. Curr. Biol. 10: 1619-1622.
36. PIANO, F. et al. 2002. Gene clustering based on RNAi phenotypes of ovary-enriched genes in C. elegans. Curr. Biol. 12: 1959-1964.
37. LEE, S.S. et al. 2003. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat. Genet. 33: 40-48.
38. KAMATH, R.S. et al. 2003. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421: 231-237.
39. ASHRAFI, K. et al. 2003. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421: 268-272.
40. POTHOF, J. et al. 2003. Identification of genes that protect the C. elegans genome against mutations by genome-wide RNAi. Genes Dev. 17: 443-448.
41. LUM, L. et al. 2003. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 299: 2039-2045.
42. HANNON, G.J. 2002. RNA interference. Nature 418: 244-251.
43. PADDISON, P.J. & G.J. HANNON. 2002. RNA interference: the new somatic cell genetics? Cancer Cell 2: 17-23.
44. FRANKISH, H. 2003. Consortium uses RNAi to uncover genes' function. Lancet 361: 584.
45. MCCAFFREY, A.P. et al. 2002. RNA interference in adult mice. Nature 418: 38-39.
46. LEWIS, D.L. et al. 2002. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32: 107-108.
47. XIA, H. et al. 2002. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20: 1006-1010.
48. HASUWA, H. et al. 2002. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532: 227-230.
49. TISCORNIA, G. et al. 2003. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 100: 1844-1848.
50. RUBINSON, D.A. et al. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33: 401-406.
51. CARMELL, M.A. et al. 2003. Germline transmission of RNAi in mice. Nat. Struct. Biol. 10: 91-92.
52. KUNATH, T. et al. 2003. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat. Biotechnol. 21: 559-561.
53. STEIN, P., P. SVOBODA & R.M. SCHULTZ. 2003. Transgenic RNAi in mouse oocytes: a simple and fast approach to study gene function. Dev. Biol. 256: 188-194.
54. CAPLEN, N.J. et al. 2002. Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum. Mol. Genet. 11: 175-184.
55. SCHERR, M. et al. 2003. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 101: 1566-1569.
56. WILDA, M. et al. 2002. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 21: 5716-5724.
57. BRUMMELKAMP, T.R., R. BERNARDS & R. AGAMI. 2002. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243-247.
58. ZHANG, L. et al. 2003. Vector-based RNAi, a novel tool for isoform-specific knockdown of VEGF and anti-angiogenesis gene therapy of cancer. Biochem. Biophys. Res. Commun. 303: 1169-1178.
59. NAGY, P., D.J. ARNDT-JOVIN & T.M. JOVIN. 2003. Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp. Cell Res. 285: 39-49.
60. Wu, H., W.N. HAIT & J.M. YANG. 2003. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res. 63: 1515-1519.
61. SLAMON, D.J. et al. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182.
62. COBLEIGH, M.A. et al. 1999. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol. 17(9): 2639-2648.
63. SLAMON, D.J. et al. 2001. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that over expresses HER2. N. Engl. J. Med. 344(11): 783-792.